8th Annual Diversity, Inclusion, & Health Equity Symposium
LEADING SYMPOSIUM DISCUSSING EQUITY IN THE HEALTH SECTOR
Chicago, IL, USA
Chicago, IL, USA
The 8th annual Diversity, Inclusion, & Health Equity Symposium is a leading annual, collaborative event focusing on health equity and health disparities in the U.S. The symposium brings together leading healthcare professionals, executives, physicians, patient groups, patients, researchers, academics, clinical trial professionals, and diversity and inclusion advocates to discuss health equity in the life sciences and the health sectors. The symposium focuses on the latest trends, challenges, opportunities in both the marketplace and workplace, with a specific focus on how to best serve an increasingly diverse patient base. We also aim to address the broader health disparity challenges in the U.S., and the symposium equips attendees with the latest insights and ideas. Attendees will learn practical solutions, share perspectives, and meet new industry and marketplace colleagues.
the world’s #1 symposium focusing specifically on health equity and diversity
clinical trials obstacles and how to make the clinical trial ecosystem more diverse and inclusive for all patients
knowledge on how to reduce health disparities by building culturally competent organizations best suited to provide care for diverse patient populations
on building inclusive organizational cultures that attracts the best and brightest people, resulting in a diverse and innovative workforce
how to strategically reduce health disparities to create a more equitable U.S. healthcare system
a workplace that embraces and promotes an inclusive environment by leveraging the latest D&I trends and ideas
to leverage a more diverse marketplace and a more inclusive workforce to create bottom line growth opportunities
and share ideas with many of the country’s leading health sector professionals who are passionate about health equity and diversity
Dr. Copeland is senior vice president of National Diversity and Inclusion strategy and policy and Chief Diversity and Inclusion officer for Kaiser Permanente.
Dr. Copeland is a member of Kaiser Permanente’s Executive Diversity and Inclusion Council, a group composed of the chairman/CEO and other C-level leaders who oversee executive accountability for embedding the diversity and inclusion strategy throughout the organization. Additionally, he is chair of the Kaiser Permanente National Diversity and Inclusion Council, which develops and implements the diversity and inclusion strategy and policy recommendations.
A board-certified general surgeon, Dr. Copeland joined Kaiser Permanente in 1988 after a six-year honorable tour of duty in the United States Air Force Medical Corps. Prior to his current role, Dr. Copeland served as president and executive medical director of the Ohio Permanente Medical Group. The Rochester, N.Y., native earned his bachelor’s degree from Dartmouth College and his medical degree from University of Cincinnati Medical College. He completed his residency in general surgery at State University of New York Upstate Medical Center in Syracuse. He also attended the Advanced Management Program at Harvard Business School.
Currently, Dr. Copeland is a member of the Council of U.S. Diversity and Inclusion Executives of The Conference Board; a fellow of The American College of Surgeons; a member of the advisory panel for Patient-Centered Outcomes Research Institute; a member of the advisory board of Talent Management Alliance; a member of Advancing Women Executives; a board member of the National Organization on Disability; a committee member of the National Quality Forum Disparities Standing Committee; and a member of True Blue Inclusion. In January 2016, Becker’s Hospital Review recognized Dr. Copeland as one of “15 hospital and health systems chief diversity officers to know.”
Bridge Clinical Research
Dr. Owen Garrick, MD, MBA, is President & COO of Bridge Clinical Research. Bridge Clinical is a global patient recruitment healthcare communications company. It is also the leading company focused on increasing the participation of minority investigators and patients in clinical trials. Dr. Garrick was formerly Director of Corporate Strategy and M&A at McKesson. Prior to McKesson, Dr. Garrick was Global Head of M&A Negotiations at Novartis. Previously he was at Goldman Sachs in New York. Dr. Garrick earned his MD from Yale, MBA from Wharton. He holds an AB from Princeton University. Dr. Garrick also serves on the boards of Sutter Health, the American Psychiatric Association Foundation and Samuel Merritt University. He was confirmed to the HHS Secretary’s Advisory Committee on Human Research Protections in 2012.
Mr. Julius Pryor III helps companies leverage Diversity & Inclusion to accelerate innovation and drive business results. He’s held executive roles at Johnson & Johnson (J&J), Coca-Cola Enterprises (CCE), Russell Athletic, Abbott Labs and Takeda Pharmaceuticals. He was Vice President of Global Diversity at both J&J and Coke. Most recently, Julius served as Head of Innovation, Diversity & Inclusion at biotech leader Genentech. Julius combines a unique vision for the future of D&I, a strong grounding in sales and management, and insights into what works across different industries and sectors. Julius saw the power of diversity to accomplish results during his 26 years of service in the U.S. Navy. He is a U.S. Navy Captain, Surface Warfare Officer and Instructor for the Navy Officer Leadership Development Program. Julius graduated from Morehouse College and The Williston Northampton School (Easthampton, MA). He sits on the boards of the Andrew Young Center for Global Leadership and the Center for Healthcare Innovation.
American Medical Association
A recognized leader in population health, Dr. LaMar Hasbrouck has led at every level of the governmental public health enterprise: local, state, federal, and global. Currently, he serves as Senior Advisor for Strategy and Growth in the Improving Health Outcomes group at the AMA where he is charged with growing relationships with health care systems, FQHCs, and other public/private organizations to promote health equity and eliminate gaps in blood pressure control and prevent diabetes across all populations.
Most recently, Dr. Hasbrouck was the Executive Director for the National Association of County and City Health Officials which represents the nation’s nearly 3,000 local health departments. Prior to that position, he was the 17th Director of the Illinois Department of Public Health responsible for protecting the health and improving the lives of the 13 million residents in the nation’s 5th largest state. While there, he helped to implement the ACA, including Medicaid expansion and the healthcare marketplace.
Dr. Hasbrouck has served on the faculty at Emory University School of Medicine, Morehouse School of Medicine, New York Medical College, and the University of Illinois at Chicago’s School of Public Health. He is a diplomat with the American Board of Internal Medicine.
He received his BA and MPH degrees from the University of California-Berkeley, and graduated Dean’s Scholar from the David Geffen School of Medicine at UCLA. His internal medicine residency took place at the New York-Presbyterian/Weill Cornell Medical Center.
Dr. Hasbrouck is the author of G Street Lion: Stalking a Dream, a revealing memoir that captures the attention and ignites the imagination of young dreamers and reinforces his personal motto: “Success requires only optimism and a stubborn belief in oneself.”
Mr. Paul Ceverha is a managing director with AArete’s healthcare strategy team. He has an extensive track record of developing new and innovative approaches to complex clinical, IT, operational, and market opportunities. Paul has served in various roles as a senior executive, program manager, CTO, industry subject matter specialist, and technical architect. He has extensive experience in, and broad knowledge of, clinical and business intelligence, and regularly advises hospital systems on the enablers required for bearing risk and improving outcomes on populations.
Mr. Loren Trimble, MBA, CPA, is the Founder, CEO, and Managing Director of AArete, a global management consulting firm. His primary focus is setting the strategic direction of the firm and creating and molding AArete’s go to market strategy and execution. In addition to Mr. Trimble’s primary focus, he also plays a significant role in thought leadership for the firm and is at the core of AArete’s Knowledge Management CenterTM. Mr. Trimble lives and breathes every day his passion for excellence with AArete’s personnel and clients. Mr. Trimble has extensive business and operations strategy experience, serving clients globally in the following industries: healthcare- provider, payer and pharmaceutical, as well as higher education, distribution, consumer products, and business services.
Mr. Marquise Stillwell is the Founder and Principal of Openbox. As a business designer and developer for more than two decades, he grounds the Openbox vision in strategic planning from the fields of investing, product development, and technology. Marquise also works in creative leadership, teaching with the KaosPilots in Denmark and South Africa to help students learn by doing. An active supporter of the arts, Marquise has collaborated with director Petter Ringbom on three short films and one feature-length movie, Shield and Spear (2014), about the rise of creative expression in post-apartheid South Africa. Marquise acts as a board member for the Lowline Underground Park and board advisor for the Andrew Goodman Foundation and MoCADA, and he is a mentor to Geeks Without Bounds and the Girls & Boys Club. He is also a supporter of the Joyce Theater, Makeshift Magazine and MCA Denver for their ability to inspire exploration and empower creative cultures. Marquise is passionate about the power of design and has a boundless curiosity for life. You can find him riding his bike through the streets of Manhattan, doing his part to build a greener urban future.
Dr. James J. Gillespie, PhD, JD, MPA, is a consultant and researcher in the advanced application of analytics and strategy to address challenges and opportunities for biopharmaceutical, healthcare, medical, and technology companies. He is the co-founder of the “Diversity, Inclusion, and Health Equity Symposium”, the leading annual event focused on D&I for the global biopharmaceutical sector. Dr. Gillespie’s research has appeared in numerous academic journals and industry periodicals. He recently authored “Attaining gender parity: Diversity 5.0 and 10 best practices for global healthcare organizations” in The Health Care Manager and “Diversity, inclusion, and precision medicine in clinical oncology” in Frontiers in Oncology. Dr. Gillespie has also published in Academy of Management Review, American Behavioral Scientist, European Journal of Social Psychology, Harvard Business Review, Life Science Leader Magazine, Pharmaceutical Executive Magazine, and Strategic Management Journal. His education includes Northwestern University Kellogg School of Management, M.A., Ph.D.; Harvard University School of Law, J.D.; Princeton University Woodrow Wilson School of Public Policy, M.P.A.; Massachusetts Institute of Technology, B.S.; Carnegie Mellon University Heinz School; and Rand Graduate School. Dr. Gillespie is an executive consultant at Kaleidoscope Group. He also serves as President & Co-Founder at the Center for Healthcare Innovation in Chicago IL and as a Project Director & Senior Advisor at the Stanford University School of Medicine in Palo Alto CA.
Rosen Bioscience Management
Mr. Michael Rosen, MBA, is a global life science connector with expertise in building global businesses (from a start-up phase beginning with university technology licensing) and life science clusters. Mr. Rosen is a developer of science parks with world-class universities with extensive experience in creating entrepreneurial faculty and identifying key areas of scientific expertise to attract international companies to co-locate at the university and commence activities in the U.S. Market. He is also actively engaged with city/state governments to attract foreign direct investment in companies co-locating at these science parks and universities. Michael was the Senior Vice President, New Business Development for the Science + Technology Group at Forest City Enterprises, a NYSE-traded real estate development company which develops and builds bioscience parks across the US. Mr. Rosen works with key research universities affiliated with Forest City bioparks, such as Northwestern University in Chicago, and endeavors to bring life science companies from Europe, Asia, Latin America, India, Israel and Canada into these parks. During his thirty-five years in the life sciences industry, he held management positions with Pfizer, Bristol-Myers Squibb, and Searle/Monsanto while living in Japan, Latin America, and Europe and worked extensively in Canada, Israel and Asia. Mr. Rosen has been President/CEO of European and US biotech and medical device companies; additionally he founded Rosen Bioscience Management to provide CEO services to start-up life science companies including a University of Wisconsin diagnostics company developing biomarkers for kidney disease, a University of Illinois company developing new cancer vaccines and a wound-care company from Michael Reese Hospital. Mr. Rosen is a founder, former Vice-Chairman and current board member of the Illinois Biotechnology Industry Organization (IBIO).
Ms. Philana Rowell, MS, is a Director of Project Leadership in clinical operations for Cardiovascular Disease and Diabetes at Sanofi. Philana has over 13+ years working in pharmaceutical clinical operations and strategic development for phase I-IV clinical research and across multiple therapeutic areas. She is adept in applying new ideas and technology to support innovative recruitment strategies for diverse inclusion in clinical research and proven success in partnering with key stakeholders to build relationships and create a culture of trust. Philana received her Bachelors of Science in pre medical studies from Fordham University in New York City and her Masters of Science in Clinical Research and Organizational Management from Drexel School of Medicine in Philadelphia, PA.
HHS Office of Minority Health
Dr. Dianne Rucinski is privileged to serve as Evaluation Officer in the Office of Minority Health (OMH) in the US Department of Health and Human Services, where she provides expert consultation and advice to the Deputy Assistant Secretary for Minority Health (DASMH) on research design and methodologies, data collection instruments, analyses, and interpretation of health data pertaining to racial and ethnic minority populations and to OMH research and policy needs.
Prior to joining OMH, Dr. Rucinski served as head of the Public Health and Epidemiology Group at Abt SRBI, a subsidiary of Abt Associates. As Vice-President at Abt SRBI she consulted on broadly on research design, survey methodology, and best research practices. Before Abt SRBI, Dr. Rucinski served as Principal Associate at Abt Associates in US Health, Public Health and Epidemiology, where she designed and directed survey research and program evaluation projects. As Senior Research Scientist at the Institute for Health Research and Policy at the University of Illinois at Chicago, Dr. Rucinski worked on numerous studies targeted on improving public health. She led several projects on health care access and utilization for the departments of Health Care and Family Services and Insurance and Professional Regulation (Illinois) and Department of Public Health (Chicago). Dr. Rucinski served as survey director at the National Opinion Research Center (NORC) where she worked on labor studies, housing studies, and health studies. Dr. Rucinski has served as external evaluator to many community organizations, using her quantitative and qualitative skills to help organizations achieve their public health goals.
Dr. Rucinski has taught research methods, public health planning and evaluation and community assessment at the Universities of Illinois-Chicago, Wisconsin-Madison, and Iowa.
Dr. Rucinski received her PhD in from the University of Wisconsin-Madison and B.S. from the University of Illinois-Urbana.
Dr. Lucy Chen, MD, is a medical director at Astellas Pharma Global Development Inc. leading a multinational phase 3 study in metastatic prostate cancer. She also serves as the Global Medical Lead for a new oncolytic virus program. As a board-certified medical oncologist, Dr. Chen joined Astellas Pharma Global Development Inc. in October 2016 after serving on the University of Illinois faculty for 6 years. She earned her bachelor’s and medical degrees from the University of Illinois and completed her residency in internal medicine at Lutheran General Hospital in Park Ridge, IL. She went on to complete a hematology oncology fellowship at the University of Chicago and was awarded the Young Investigator Award by the American Society of Clinical Oncology (ASCO).
Ms. Celeste Warren, MS, is Vice President, Human Resources & Global Diversity and Inclusion Center of Excellence. In this dual role, she has responsibility for the strategic and operational Human Resources support of Merck’s Global Legal, Compliance, Communications, Population Health, Patient Health and Global Public Policy Organizations. As the leader for Merck’s Global Diversity and Inclusion Center of Excellence, she is responsible for working with Merck’s global leaders to advance and embed diversity and inclusion as a strategic approach to maximize business performance and create a competitive advantage. Ms. Warren joined Merck in 1997 and has held numerous positions of increasing responsibility within its Human Resources organization. During her tenure at Merck, Ms. Warren has supported various different businesses and corporate staff functions.
Dr. Jeffrey (Jeff) W. Sherman, MD, FACP, is Chief Medical Officer and Executive Vice President at Horizon Pharma. Jeff has more than 25 years of experience in the pharmaceutical industry at IDM Pharma, Takeda Global Research and Development, NeoPharm, Searle/Pharmacia, and Squibb/Bristol-Myers Squibb. He also serves on the Board of Directors of Strongbridge Biopharma. Jeff is an Adjunct Assistant Professor of Medicine at the Northwestern University Feinberg School of Medicine and a Diplomat of the National Board of Medical Examiners and the American Board of Internal Medicine. Jeff received his bachelor degree in biology from Lake Forest College and medical degree from the Rosalind Franklin University of Medicine and Science/The Chicago Medical School.
Ms. Allecia Harley, MPH, is the Associate Vice President of Clinical Research Administration in the Office of Research Affairs at Rush University and is Certified Clinical Research Professional (CCRP). Allecia has 20+ years of experience in clinical research working for pharmaceutical companies, contract research organizations, a consulting firm, and an academic medical center. Prior to joining Rush, Allecia was a Director at Huron Consulting Group, where she provided oversight to multidisciplinary project teams that assisted academic medical centers, NCI designated cancer centers, and health systems with complex regulatory challenges in research administration. Allecia received her Bachelor of Science in Biology from Spelman College in Atlanta and a Master of Public Health in Epidemiology from the University of Michigan in Ann Arbor.
Ms. Keya Pitts, MPH, is Executive Director, Clinical and Pharmacovigilance Quality Assurance at Astellas Pharma. Keya has over 22 years of experience in the pharmaceutical industry, holding management positions within clinical development, pharmacovigilance, and quality at companies such as AstraZeneca and Purdue Pharma. She is widely respected for her leadership and strategy setting capabilities and expertise in the highly regulated environment of pharmaceutical development, having authored industry publications and serving as guest speaker at conferences since 1999. Keya actively supports initiatives supporting girls and young women as future leaders in the pursuit of STEM careers and education. She holds an MPH degree from Johns Hopkins University Bloomberg School of Public Health, and a BA in General Sciences from Cheyney University.
Dr. Bonnie Lai, PhD, is Vice President, Product at Lumere, formerly Procured Health. Prior to Lumere, Dr. Lai worked for five years at The Boston Consulting Group (BCG), a management consulting firm where she served clients across the healthcare industry (pharmaceuticals, medical devices, payers, providers). Dr. Lai was a member of BCG’s Career Development Committee responsible for performance evaluation and a recipient of the Journeyman Award for people development. Dr. Lai holds a bachelor’s from Northwestern University and PhD from Duke University in biomedical engineering.
Aurora Health Care
Ms. Erickajoy Daniels, MS, is a community resource, with nearly two decades of development and consulting experience. She currently leads the system-wide rollout of diversity and inclusion efforts at Aurora Health Care. Previously, Erickajoy was responsible for organizational development and talent management at Milwaukee’s Brady Corporation. She also held employee development positions at the Federal Bureau of Prisons in Washington, D.C. Erickajoy serves on the board of Betty Brinn Children’s Museum and is a trustee at Mount Mary University. She is active in TEMPO Milwaukee Professional Women’s Network and is co-founder and board member of One MKE, an organization dedicated to addressing cultural divides in the Milwaukee community.
Ms. Cherie Coleman, MSC, is currently Program Manager within the Payment Innovation Division at Anthem, Inc., the nation’s largest health benefit company. She’s focused on operations management for their Enhanced Personal Health Care Program models which delivers excellence for the five dimensions of a high performance health system: quality, access, efficiency, equity and healthy lives. Cherie has held a leadership role in various capacities within the Health Care industry beginning her career at the University of Chicago Hospitals. In 2012 she joined the IL Diversity Council as the Activities and Events Chair. In the Fall of 2016, Cherie became a Certified Diversity Professional (CDP) and stepped into the role of Advisory Board President. She received a Masters in Communications degree with an emphasis is Business Leadership and Change Management from Northwestern University.
Illinois Medical District
Dr. Suzet M. McKinney, DrPH, MPH, currently serves as CEO/Executive Director of the Illinois Medical District. Dr. McKinney is the former Deputy Commissioner of the Bureau of Public Health Preparedness and Emergency Response at the Chicago Department of Public Health (CDPH), where she oversaw the emergency preparedness efforts for the Department and coordinated those efforts within the larger spectrum of the City of Chicago’s Public Safety activities, in addition to overseeing the Department’s Division of Women and Children’s Health. In academia, Dr. McKinney serves as an Instructor in the Division of Translational Policy and Leadership Development at Harvard University’s T.H. Chan School of Public Health and as Adjunct Assistant Professor of Environmental and Occupational Health Sciences at the University of Illinois at Chicago School of Public Health.
Ms. Laurinda Dodgen, MPH, is a community strategist with AARP. She has extensive experience working collaboratively with community, governmental and business partners to address public health needs. She led the AARP state office in engaging communities of color and lobbied to pass the Illinois Secure Choice Savings Program (SB2758) that was endorsed by the Black and Hispanic caucuses. Laurinda is the co-founder of the International Sports Exchange Program, a youth sports based exchange program between the US and Turkey. She serves on the Board of Directors for Chicago Housing Authority’s (CHA) non-profit Springboard to Success. Laurinda received her BA in Kinesiology and a Masters of Public Health Administration from Northern Illinois University. She also holds a Masters of Public Policy and Administration from Northwestern University.
Clark Atlanta University
Dr. Kimberly E. Davis, PhD, MS, is a Senior Research Scientist and Director of the Community Outreach Core in CCRTD at Clark Atlanta University. Dr. Davis received her B.S. and M.S. degrees from Alabama A&M University and Ph.D. degree from Florida State University. Her research emphasis includes research in cancer health disparities and falls into four broad categories: cancer etiology, nutritional epidemiology, minority participation in research studies, and cancer survivorship. She conducts research to study relationships between various dietary factors and prostate cancer risk, with an emphasis on racial and ethnic disparities.
Dr. Karen Correa, PhD, MS, is currently Senior Director, Clinical Operations at Adare Pharmaceuticals and a Board Member of CAMcare a Federally Qualified Healthcare Center and Susan G. Komen South Central Jersey Affiliate. Dr. Correa is a published author that has provided strategy and innovation to pharmaceutical companies, clinical sites on diversity inclusion in clinical trials, health disparities, health equity, and patient advocacy. Dr. Correa holds a BS in Biology from East Carolina University, MSA from Central Michigan University, and a Ph.D. in International Health Research from Trident university. She has utilized her educational experience and knowledge to inspire young women and girls via motivational speaking events and workshops in the pursuit of STEM careers and education.
Dr. Parag Aggarwal, PhD, is Associate Director for the Healthcare Delivery and Disparities Research program at the Patient-Centered Outcomes Research Institute (PCORI). Before joining PCORI, Dr. Aggarwal worked for Deloitte Consulting LLP, where he led engagements focused on life science and healthcare strategy through the translation medicine team. He provided subject matter expertise across multiple areas, including healthcare regulatory agencies, life science and pharmaceutical companies, and non-profit organizations. He developed strategies that combined science, business, and regulatory components to enable efficient business operations for life science and healthcare organizations. Dr. Aggarwal received his PhD in Medicinal Chemistry from the University of Michigan.
Ms. Shradha Agarwal is President & Co-founder of Outcome Health (formerly Context Media). In 2006, Shradha co-founded ContextMedia, a healthcare media company that delivers lifestyle education to 30M patients each month nationally. As President of the fast-growing company, Shradha is focused on product innovation, scaling operations and talent development. Shradha co-founded JumpStart Ventures in 2011 to fund other passionate entrepreneurs who are executing ambitious solutions in healthcare, education and media communications. She serves on the boards of OneGoal and Chicago Children’s Choir and spiritedly supports youth education, women leadership, and civic engagement. Shradha was also recognized as a Champion of Change by the White House and awarded the Prominent Woman in Tech by ITA.
Leveraging successful roles in healthcare marketing, integrated communications, medical education and public relations, Tammy created advocacy offerings at three pharmaceutical companies and a healthcare communications agency. She is adept in identifying and collaborating with key patient groups to develop symbiotic initiatives. Included in her experience is development of diversity and inclusion programming to ensure disproportionately impacted populations receive resonant messaging, via appropriate language and mediums. Tammy has lead unbranded educational patient advocacy outreach campaigns, translating messaging into language that resonates with patients, caregivers and healthcare professionals, communicating to the community at large about the implications and impact on treatment decisions, patient empowerment and healthcare reform.
GE Healthcare Camden Group
Dr. David DiLoreto, MD, MBA, Senior Vice President at GE Healthcare Camden Group, is a physician-executive who is highly experienced in executive management, strategy and operations of healthcare delivery systems, and managed care companies. He has deep management expertise in community-based and academic health systems, large group medical practices, hospitals, and managed care organizations. Prior to joining GE Healthcare Camden Group, Dr. DiLoreto was the Chief Clinical Officer at Presence Health. Dr. DiLoreto is a board-certified ophthalmologist and a graduate of the University of Florida College of Medicine. He holds a master’s degree in business administration Emory University, in Atlanta, Georgia. He earned his bachelor of science degree from Loyola University in New Orleans, Louisiana.
Dr. Melva Covington, PhD, MPH, MBA, is Senior Director, Health Outcomes & Value Assessment at Pacira Pharmaceuticals. Prior to joining Pacira, Dr. Covington is a leader within Global Research and Development at Sanofi. Her leadership skills, expertise and impact has spanned throughout the drug development lifecycle process for over 15 years. She has a broad background in health services research and applies critical thinking, business management and scientific innovation strategically to address complex issues within the healthcare community. Her goal is to apply knowledge contextually to understand the patterns of health care conditions in society as well as more targeted so as to focus on the specific needs of individuals and diverse communities. She has MPH and PhD from the University of North Carolina and MBA from Cornell University. Dr. Covington has authored numerous publications and is an impassioned public speaker. Much of her work focuses on addressing population-based disparities in health outcomes and cultural competency.
Mr. Bert Bruce, MBA, is Vice President, Global Marketing, Rare Disease at Pfizer. His responsibilities span drug development, business development, commercial preparedness and lifecycle management for development and commercialized Rare Disease medicines. Bert has a diverse skill set and broad pharmaceutical background, with leadership experiences across multiple therapeutics areas and disciplines and Johnson & Johnson, Wyeth and Pfizer. Bert earned a B.S. from Eastern College and an M.B.A. from the University of Pennsylvania’s Wharton School of Business. He is well recognized for his strategic vision, collaborative leadership, influencing skills, and development of high-performing teams; his professional passions include improving the participation of minorities in clinical trials and leadership development.
Ms. Dima Elissa, MBA, is the CEO and founder of VisMed-3D, a medical 3D printing company. She is also the Diversity, Inclusion, and Innovation (D & I2) – Tech & Innovation Lead at American Medical Women’s Association. As an adjunct faculty member teaching Entrepreneurship at the Associated Colleges of the Midwest in Chicago and in-demand speaker, she exemplifies her commitment to giving back and paying it forward. She currently serves on the boards of mHUB Chicago, BWG Strategy LLC, Ms. Tech, Women in Bio, Galvanize Labs, and is on the STEM steering committee for the Aparecio Foundation, which provides mentoring to high-achieving, low- income female high school students. Dima holds a B.A. in Chemistry from Hanover College, and earned her MBA from Texas A&M’s May’s School of Business with a concentration in Finance.
191 N. Wacker Drive | Suite 3700
Chicago, IL, USA 60606
Please contact us with any symposium questions.